Literature DB >> 79321

Drusen of the optic nerve head.

S W Boyce, E V Platia, W R Green.   

Abstract

Fifty-two eyes with drusen of the optic nerve head from the autopsy and surgical files of the Eye Pathology Laboratory of the Wilmer Institute from January 1967 through December 1975 were reviewed, and histochemical and electron microscopic studies performed. Histopathologic associations with the drusen included 19 eyes with associated optic nerve atrophy, 16 eyes with peripapillary crowding, one case involving prominent dilated vessels pushed aside by the drusen, and one eye with central retinal vein occlusion. Drusen appear to be composed predominantly of a mucoprotein matrix with significant quantities of acid mucopolysaccharides along with small quantities of ribonucleic acid and, occasionally, iron. The literature is reviewed and various correlations and pathogenetic theories are discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 79321

Source DB:  PubMed          Journal:  Ann Ophthalmol        ISSN: 0003-4886


  5 in total

Review 1.  [Optic disc drusen].

Authors:  M Schargus; E Gramer
Journal:  Ophthalmologe       Date:  2008-07       Impact factor: 1.059

2.  Imaging of optic nerve head drusen with the scanning laser ophthalmoscope.

Authors:  R J Haynes; A Manivannan; S Walker; P F Sharp; J V Forrester
Journal:  Br J Ophthalmol       Date:  1997-08       Impact factor: 4.638

3.  The cost-effectiveness of different strategies to evaluate optic disk drusen in children.

Authors:  Marlen Leon; Amy K Hutchinson; Phoebe D Lenhart; Scott R Lambert
Journal:  J AAPOS       Date:  2014-09-27       Impact factor: 1.220

4.  Scanning laser polarimetry (SLP) for optic nerve head drusen.

Authors:  A Mistlberger; S Sitte; A Hommer; M Emesz; S Dengg; W Hitzl; G Grabner
Journal:  Int Ophthalmol       Date:  2001       Impact factor: 2.031

5.  Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases.

Authors:  W R Green; C C Chan; G M Hutchins; J M Terry
Journal:  Trans Am Ophthalmol Soc       Date:  1981
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.